J. Robin Harris
Springer Netherlands
e druk, 2015
9789400797369
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
Specificaties
Paperback, blz.
|
Engels
Springer Netherlands |
e druk, 2015
ISBN13: 9789400797369
Rubricering
Onderdeel van serie
Subcellular Biochemistry
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This volume of the Subcellular Biochemistry series is the result of the long-standing research interest of the editor in the molecular mechanism underlying Alzheimer’s disease and other amyloid diseases, indicated also by the earlier book in the series (Volume 38), devoted to Alzheimer’s disease. The broad coverage within the present amyloidogenesis book represents an attempt to collate current knowledge relating to the proteins and peptides involved in most of the known amyloid diseases, together with some amyloid/fibril-forming proteins and peptides that are not involved in diseases. Thus, the range of topics included is comprehensive and furthermore it was thought appropriate to include both basic science and clinical presentation of the subjects under discussion.
Specificaties
ISBN13:9789400797369
Taal:Engels
Bindwijze:paperback
Uitgever:Springer Netherlands
Serie:Subcellular Biochemistry
Inhoudsopgave
<p>I. Introduction</p><p>1. Introduction and Technical Survey; J. Robin Harris and Nathaniel G. Milton <p>II. Basic Science</p><p>2. Fibril Formation by Short Synthetic Peptides; Andrew Smith </p><p>3. In vitro Oligomerization and Fibrillogenesis of Amyloid-beta Peptides; Núria Benseny-Cases, Oksana Klementieva and Josep Cladera<p>4. Tau Fibrillogenesis; Nitin Chaudhary and Ramakrishnan Nagaraj<p>5. Prion protein Aggregation and Fibrillogenesis In vitro; Jan Stöhr</p><p>6. α-Synuclein Aggregation and Modulating Factors; Katerina E. Paleologou and Omar M. A. El-Agnaf</p><p>7. Pathological Self-aggregation of β<sub>2</sub>-microglobulin: A Challenge for Protein Biophysics; Gennaro Esposito, Alessandra Corazza, and Vittorio Bellotti</p><p>8. Islet amyloid polypeptide – Aggregation and fibrillogenesis in vitro and its Inhibition; Janine Seeliger and Roland Winter</p><p>9. Mechanisms of Transthyretin Aggregation and Toxicity; Robert J. Gasperini, David W. Klaver, Xu Hou, Marie-Isabel Aguilar and David H. Small<p>10. Fibrillogenesis of Huntingtin and Other Glutamine Containing Proteins; Yuri L. Lyubchenko, Alexey V. Krasnoslobodtsev and Sorin Luca</p><p>11. Aggregation and Fibrillogenesis of Proteins not Associated with Disease – A few Case Studies; Moritz Lassé, Juliet A. Gerrard<sup> </sup>and <sub> </sub>F. Grant Pearce<p>12. Experimental Inhibition of Peptide Fibrillogenesis by Synthetic Peptides, Carbohydrates and Drugs; Alagiri Srinivasan</p><p>13. Experimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (Aβ) and other disease-related peptides/proteins by plant extracts and herbal compounds; Suresh Kumar, Edward Okello and J. Robin Harris</p><p>III. Clinical Science: The Cerebral and Systemic Amyloid Diseases</p><p>Pathogenesis and therapeutic consideration of the major disorders<p>14. Alzheimer’s Disease; Vanessa J. De-Paula, Marcia Radanovic, Breno S. Diniz, Orestes V. Forlenza</p><p>15. Modeling the Polyglutamine Aggregation Pathway in Huntington’s Disease: from Basic Studies to Clinical Applications;<br> Keizo Sugaya</p><p>16. Parkinson’s Disease; Timothy R. Mhyre, James T. Boyd, Robert W. Hamill, and Kathleen Maguire-Zeiss</p><p>17. Human Prion Diseases: From Kuru to Variant Creutzfeldt-Jakob Diseasae; Beata Sikorska and Paweł P. Liberski</p><p>18. Animal Prion Diseases; Otto Windl and Mike Dawson</p><p>19. β<sub>2</sub>-microglobulin Amyloidosis; Dorthe B. Corlin and Niels H.H. Heegaard</p><p>20. Systemic AA Amyloidosis; Jennifer H Pinney and Helen J Lachmann</p><p>21. Familial Amyloidotic Polyneuropathy and Transthyretin; Takamura Nagasaka 22. The Challenge of Systemic Immunoglobulin Light-chain Amyloidosis (AL); Giovanni Palladini and Raymond L Comenzo</p>